Tsuyoshi Sasaki

USPTO Granted Patents = 16 (Patent Applications = 1)

CIPO Patents = 10

EPO Patents = 9 (Patent Applications = 8)

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 41(Granted Patents)

Location History:

Kagoshima, JP (2003 - 2008)
Tokyo-to, JP (2014)
Tokyo, JP (1996 - 2022)
Osaka, JP (2017 - 2023)

Company Filing History:

8 out of 665

Yoshino Kogyosho Co., Ltd.

patents

3 out of 1,177

Takeda Pharmaceutical Company Limited

Mitsubishi Electric Corporation

patents

5. 1 out of 6

Sumitomo Pharma Switzerland Gmbh

patents

6. 1 out of 1,007

Shiseido Company, Limited

patents

where one patent can have more than one assignee

Years Active: 1996-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12338249 - Crystalline forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea (2025-06-24),

2. 11795178 - Compositions of thienopyrimidine derivatives (2023-10-24),

3. 11433409 - Spouting container (2022-09-06),

4. 11271639 - Communication system, repeater, control station, and control method (2022-03-08),

5. 10758925 - Foamer dispenser, and container with foamer dispenser (2020-09-01),

6. 10376909 - Pump type dispenser (2019-08-13),

7. 10144026 - Foamer dispenser, and container with foamer dispenser (2018-12-04),

8. 9839924 - Foamer dispenser (2017-12-12),

9. 9758528 - Production method of thienopyrimidine derivative (2017-09-12),

10. 9585527 - Foamer dispenser (2017-03-07),

11. 9579670 - Dispensing container (2017-02-28),

12. 9473236 - Relay apparatus, relay satellite, and satellite communication system (2016-10-18),

13. 8910673 - Synthetic resin bottle, and a combination of regularly used container and refill container (2014-12-16),

14. RE40409 - Photoelectric converter having a light receiving portion with an improved readout gate (2008-06-30),

15. 6515268 - Photoelectric converter having a light receiving portion with an improved readout gate (2003-02-04),

Title: Tsuyoshi Sasaki: Innovator in Pharmaceutical Chemistry

Introduction

Tsuyoshi Sasaki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 16 patents. His work focuses on the development of novel compounds and methods that have potential therapeutic applications.

Latest Patents

One of his latest patents involves the crystalline forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea. This disclosure relates to novel crystalline forms, methods of making these forms, and pharmaceutical compositions that include them. Another significant patent pertains to the production method of thienopyrimidine derivatives, which exhibit gonadotropin-releasing hormone (GnRH) antagonistic action. This invention provides a high-quality production method with high yield.

Career Highlights

Throughout his career, Tsuyoshi Sasaki has worked with notable companies such as Yoshino Kogyosho Co., Ltd. and Takeda Pharmaceutical Company Limited. His expertise in pharmaceutical chemistry has led to advancements in drug development and therapeutic solutions.

Collaborations

He has collaborated with esteemed colleagues, including Hiroshi Mizushima and Koichiro Fukuoka, contributing to various innovative projects in the pharmaceutical sector.

Conclusion

Tsuyoshi Sasaki's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.